Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mozobil with MEC in Relapsed or Refractory AML
NCT00512252Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jul 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of plerixafor in acute myeloid leukemia (AML), sponsored by Washington University School of Medicine. Started Jul 2007; status: completed.
02
Drugs
plerixafor
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00512252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00512252.